PARKINSONíS INSTITUTE AND CLINICAL CENTER TO PROVIDE ACCESS TO MOBILE HEALTH TECHNOLOGY FOR ASSESSMENT AND MONITORING OF MOVEMENT DISORDERS
 
Published Friday, January 15, 2016

Sunnyvale, CA, January 15, 2016----The Parkinson’s Institute and Clinical Center announces their partnership with Global Kinetics Corporation (GKC) in a pilot program that will provide Institute patients with access to an innovative mobile health technology. The Personal KinetiGraph™ (PKG™) is a wrist-worn device that offers comprehensive, automated reporting of a Parkinson’s patient’s movements so that neurologists and other physicians can objectively assess symptoms and response to medications.

The PKG Data Logger features a vibrating medication reminder which allows patients to record when they have taken their levodopa medication as prescribed by their doctor.  The device is worn continuously for six consecutive days in the home environment and it records movement via a digital accelerometer. The data recorded by the PKG Data Logger enables a report to be generated which visually illustrates for the clinician the severity of movement disorder symptoms in relation to the timing of levodopa medication, as well as valuable information on medication use. 


Click on the picture to view PKG instructional video

Global Kinetics Corporation co-founder and Chief Scientific Officer, Professor and neurologist Malcolm Horne remarks “GKC has long held the view that actionable data matters in Parkinson’s, and access to PKG data allows clinicians to provide optimum treatment, leading to enhanced quality of life for patients and superior health cost outcomes. When clinicians have PKG information they can make more informed decisions for optimal symptom management and ultimately enable improved quality of life. We look forward to working with the Parkinson’s Institute to make this important technology available and accessible to people living with Parkinson’s.” 

“We are pleased to provide the PKG System to our patients”, states Carrolee Barlow, MD, PhD and CEO of the Parkinson’s Institute. Dr. Barlow explains, “Dr. Horne developed the device to address a fundamental problem facing doctors trying to optimize the treatment of their patients with Parkinson’s.  The PKG system delivers the data from the logger to the physician in a series of graphs—known as a Personal KinetiGraph—that the doctor can interpret and discuss with the patient in order to make better and more objectively informed decisions.” Dr. Barlow notes that, “Dr. Horne suggests that the algorithm and interpretation sets it apart from all the other “wearable” technology which are used for personal health because this system has been FDA cleared to be used by doctors to assess a person Parkinson’s symptoms.  We are thrilled to be able to partner with GKC to bring this innovative technology to our patients.”

The PKG technology received FDA clearance in September 2014 and is being progressively adopted by clinics in the USA. This new technology is currently being utilized by movement disorder clinicians across Europe, Asia and Australia.  

To make a new appointment with a Parkinson’s Institute and Clinical Center Movement Disorders Specialist please call 408-734-2800.

For more information on the Personal KinetiGraph™ please go to www.globalkineticscorp.com. 

About the Parkinson’s Institute and Clinical Center
Almost 30 years ago, Dr. J. William Langston and a dedicated team of Parkinson’s disease experts set out to create a better way to research and provide care for Parkinson’s disease. The result was the Parkinson’s Institute and Clinical Center— world renowned for its exemplary patient care and for driving innovations and advances in Parkinson’s. Based in Sunnyvale, California the Institute is America’s only independent non-profit organization combining world-class care, clinical research, laboratory research, and clinical trials for Parkinson’s disease under one roof. Patients and scientists become partners in developing care plans, improving their quality of life, and discovering new strategies to confront and manage their disease. Compassionate care works hand-in-hand with cutting-edge research to seek answers, develop new therapies, and ultimately work toward a cure. Through the generous support of donors the Institute has helped thousands of Parkinson’s patients, partnered with pharmaceutical companies to test new therapies, and is leading the way by providing groundbreaking research to close the gap between science, clinical care and new therapies. Visit ParkinsonsInstitute.org, Facebook.com/PDpartner, and Twitter.com/PDpartner or call direct to (408) 734-2800 or toll free, (800) 655-2273. 

About Global Kinetics Corporation
Global Kinetics Corporation is committed to improving the lives of those with Parkinson’s disease and other movement disorders with advanced medical technologies. The company was formed in 2007 to commercialize its lead product, the Personal KinetiGraph™ (PKG™). Developed by neurologists at the world-renowned Florey Institute of Neuroscience & Mental Health in Melbourne, Australia, the Personal KinetiGraph enables the precise monitoring, quantification and reporting of movement symptoms of neurological diseases. Global Kinetics Corporation, a privately held company, is headquartered in Melbourne, Australia. For more information visit: www.globalkineticscorporation.com 


Send this page to a friend

Show Other Stories

675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)